tiprankstipranks
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market
2096
Simcere Pharmaceutical Group Limited
RESEARCH TOOLSreports
Want to see HK:2096 full AI Analyst Report?

Simcere Pharmaceutical Group Limited (2096) Income Statement

4 Followers

Simcere Pharmaceutical Group Limited Income Statement

Last quarter (Q4 2025), Simcere Pharmaceutical Group Limited's total revenue was ¥4.08B, an increase of 26.29% from the same quarter last year. In Q4, Simcere Pharmaceutical Group Limited's net income was ¥728.05M. See Simcere Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 7.53B¥ 6.64B¥ 6.61B¥ 6.32B¥ 5.00B
Gross Profit
¥ 6.15B¥ 5.32B¥ 4.98B¥ 5.00B¥ 3.92B
Operating Expenses
¥ 4.92B¥ 4.48B¥ 4.27B¥ 4.14B¥ 2.47B
Depreciation and Amortization
¥ 370.98M¥ 214.29M¥ 309.59M¥ 209.04M¥ 189.12M
EBITDA
¥ 1.60B¥ 1.35B¥ 1.08B¥ 815.38M¥ 422.45M
Operating Income
¥ 1.22B¥ 848.05M¥ 711.80M¥ 862.50M¥ 1.45B
Other Income/Expenses
¥ 250.75M¥ -28.17M¥ 28.24M¥ 25.65M¥ -46.75M
Pretax Income
¥ 1.48B¥ 819.88M¥ 740.04M¥ 888.15M¥ 1.40B
Net Income
¥ 1.31B¥ 733.16M¥ 714.76M¥ 930.87M¥ 1.51B
Per Share Metrics
Basic EPS
¥ 0.53¥ 0.29¥ 0.27¥ 0.36¥ 0.58
Diluted EPS
¥ 0.53¥ 0.29¥ 0.27¥ 0.36¥ 0.58
Weighted Average Shares Outstanding
 2.48B 2.53B 2.65B 2.61B 2.61B
Weighted Average Shares Outstanding (Diluted)
 2.49B 2.52B 2.61B 2.62B 2.61B
Currency in CNY

Simcere Pharmaceutical Group Limited Earnings and Revenue History